Clinical Trial RESULTS
WHERE CAN I LEARN MORE ABOUT THE STUDY?
If you have questions about the results, please speak with the doctor or staff at your study site.
You can find more information about your study online at
www.clinicaltrials.gov/show/results/NCT02484729.
Official study title: A Phase I, Randomized, Single-Blind, Placebo-Controlled Study to Assess
the Safety, Tolerability, and Pharmacokinetics of AZD9977 Following Single Ascending Dose
Administration to Healthy Male Subjects
Astra Zeneca AB, the sponsor of this study, is a member of the AstraZeneca group of companies
and has its headquarters at 1800 Concord Pike, PO Box 15437, Wilmington, DE 19850.
The phone number for general information is 1-877-240-9479.
The results presented here are for a single study. Other studies may provide new
information or different results. You should not make changes to your therapy based on the
results of a single trial without first consulting your healthcare professional.
Thank you
It is said that the greatest gift is one which is
given anonymously, giving when you do not know
whether you will get direct personal benefit.
This is the gift that you have given by taking part in a
clinical trial. It is a brave and selfless act, one that advances
medical knowledge and benefits public health.
Thank you for the gift of your participation in clinical research.
The Center for Information & Study on Clinical Research Synchrogenix is a worldwide medical and regulatory
Participation (CISCRP) is a non-profit organization writing organization and is not involved in recruiting
focused on educating and informing the public about participants or in conducting clinical trials.
clinical research participation. CISCRP is not involved
in recruiting participants for clinical trials, nor is it
involved in conducting clinical trials.
CISCRP Synchrogenix Headquarters
56 Commercial Wharf East 2 Righter Parkway, Suite 205
Boston, MA 02110 Wilmington, DE 19803
1-877-MED-HERO 1-302-892-4800
www.ciscrp.org www.synchrogenix.com
8
Trial Results Summary v1 06/2016